Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Preventing and Managing Treatment-Related Lymphedema

      February 6, 2014
      By Jennifer Smith, MSN, CNP
      Lauren McCaulley, MSN, RN, OCN
      Publication
      Article
      Oncology Nursing NewsDecember 2013
      Volume 7
      Issue 9

      Cancer-related lymphedema can result from the cancer or its treatment. It is an accumulation of protein-rich fluid in an interstitial space which may be the result of surgical resection, lymph node dissection, or radiation therapy

      Jennifer Smith, MSN, CNP

      Lauren McCaulley, MSN, RN, OCN

      Jennifer Smith is a Survivorship Nurse Practitioner at the Louis Stokes Cleveland VA Medical Center, and Lauren McCaulley is the Assistant Nurse Manager for the Women’s Surgical Oncology unit at University Hospitals Seidman Cancer Center in Cleveland, Ohio.

      Cancer-related lymphedema can result from the cancer or its treatment. It is an accumulation of protein-rich fluid in an interstitial space which may be the result of surgical resection, lymph node dissection, or radiation therapy.1 Lymphedema is a chronic condition that impacts all domains of quality of life, including physical, psychological, social, and spiritual. Lymphedema can impair function and cause disabling physical symptoms as a result of the swelling. Anxiety, depression, and distress are commonly associated with lymphedema, and the disfiguring physical changes can have a negative impact on social-wellbeing and relationships.2

      The incidence of cancer-related lymphedema ranges from about 1% to as high as 48% (Box).3 Approximately 25% of breast cancer patients who undergo axillary lymph node dissection develop lymphedema the first 3 years following surgery.

      The Role of the Oncology Nurse

      The oncology nurse plays a major role in the prevention, detection, and management of lymphedema. Identifying patients at risk who need intensive education about self-care strategies to prevent the initial development of lymphedema is the first step in prevention. Patients at risk include those who have undergone surgical procedures, such as tumor debulking with lymph node dissection or radiation therapy involving lymphatic beds. Additional risk factors associated with lymphedema include advancing age, obesity, venous impairment, and comorbid conditions including diabetes.

      Nurses can teach patients who are at risk4:

      • Activities that promote lymph fluid drainage (eg, lymph drainage exercises)
      • Appropriate use of preventive compression garments
      • Safe practices that avoid trauma to the at-risk area or limb (eg, avoiding heavy use of the extremity, phlebotomy, or blood pressure readings in the affected limb)
      • Skin care
      • How to identify early signs and symptoms of lymphedema for rapid intervention

      Education can begin prior to starting cancer treatment and continue following surgery or throughout radiation therapy. For example, patients who may be candidates for a lymph node dissection should be fitted with a compression garment prior to surgery so that there is no lag time between the surgery and the acquisition of the compression garment. Ongoing assessment and surveillance is recommended 1 month postoperatively and at 3-month intervals for an additional 18 months.5

      Incidence of Treatment-Related Lymphedema in Survivors3

      Breast: 40%

      Gynecologic: 20%

      Melanoma: 16%

      Genitourinary: 10%

      Head and Neck: 4%

      Teaching patients how to monitor and assess for the early signs and symptoms of lymphedema will increase the chance that patients will seek medical help at the onset. Although there is no cure, early-stage intervention improves the likelihood of response to treatment and minimizes long-term consequences.

      Detection of lymphedema is challenging as fluid shifts may be subtle. Both objective measurements and symptom assessment are combined when making the diagnosis.6 Patients expected to undergo lymph node dissection should have preoperative/ treatment measurements taken to document preexisting normal inter-limb variance.5

      Limb volume measurements need to be done in a consistent manner. Although there are a variety of measurement techniques and tools, limb circumference is the most common technique and is valid and reliable when performed correctly.7 A change of >2 cm from baseline at any point along the 2 cm interval measurements of the limb is the criterion for lymphedema.2

      Management

      The goal of treatment is to slow progression of lymphedema, provide symptom relief, maintain skin integrity and prevent complications or infection, and maintain psychosocial wellbeing.1 Complete decongestive therapy is the gold standard of treatment according to the international Lymphedema Framework.7 Certified therapists perform manual lymph drainage daily for a 3- to 8-week period. During that time, nurses work with physical therapists to teach patients to use compression bandaging and specific exercises to promote drainage from the congested area. Nurse support and reinforcement of the treatment plan promotes adherence for management of this chronic condition.

      Oncology nurses play a major role in the prevention, early detection, and treatment of lymphedema— one of the most distressing side effects of certain types of cancer and its treatment. They provide extensive education for prevention, teach patients how to use and care for compression garments, and work with the oncology team for appropriate referral for manual lymphatic drainage.

      A multidisciplinary approach to care, utilizing physical therapists, psychologists, and social workers is essential to address the impact of lymphedema on quality of life.

      Oncology nurses can increase their knowledge and expertise in managing this symptom and collaborate with other nurses interested in lymphedema by becoming members of the Lymphedema Management Special Interest Group (SIG) of the Oncology Nursing Society

      References

      • Ryan JC, Cleveland CM, Fu, MR. Predictors of practice patterns for lymphedema care among oncology advanced practice nurses. J Adv Pract Oncol. 2012;3(5):307-318.
      • Torres Lacomba M, Yuste Sanchez MJ, Zapico Goni A, et al. Effectiveness of early physiotherapy to prevent lymphedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010;340:b5396-b5404.
      • Cormier JN, Askew RL, Mungovan KS, Xing Y., Ross MI, Armer JN. Lymphedema beyond breast cancer: A systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 2010;116(22):5138- 5149.
      • Ridner SH. Pretreatment lymphedema education and identified resources in breast cancer survivors. Patient Educ Couns. 2006;61(1):72-79.
      • Stout Gergich NL, Pfalzer L, McGarvey C, Springer B, Gerber LH, Soballe P. Peroperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809-2819.
      • McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axiliary dissection: patient perceptions and precautionary behaviors. J Clin Oncol. 2008;26(32):5220-5226.
      • Lymphedema Framework. Best Practice for the Management of Lymphedema. International consensus. London: MEP, Ltd; 2006. http://ewma. org/fileadmin/user_upload/EWMA/Wound_Guidelines/Lymphoedema_ Framework_Best_Practice_for_the_Management_of_Lymphoedema.pdf. Accessed November 22, 2013.

      Articles in this issue

      Aldoxorubicin More Effective Than Doxorubicin in STS
      PARP Inhibitors Reemerge as Treatment for Serous Ovarian Cancer
      ALK-Positive Criteria for Determining Crizotinib Use May Fall Short
      Subgroup Analyses Show Depth of Everolimus Benefit in BOLERO-2
      Stem Cell Transplantation May Impair Sexual Health
      Analysis Finds Cancer Care Coordination Increases Patient Satisfaction
      Standardizing Palliative Care Referrals and Distress Assessment
      Evidence-Based Guidelines Needed for Immunotherapy-Related Adverse Events
      Preventing and Managing Treatment-Related Lymphedema
      Studies Demonstrate Potential of Immunomodulation as Therapeutic Target in Gynecologic Cancers
      Offering Durable Responses With Less Toxicity in Melanoma
      Provenge Treatment Team Supports Patients Every Step of the Way
      Exploring the Leadership Role of Advanced Practice Provider Manager
      Helping Patients to Manage Dermatologic Toxicities: An Interview With Kathryn Ciccolini, RN, BSN, OCN
      Immunotherapy Poised to Transform Cancer Treatment

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Image of a woman with gray hair on a light blue background
      Photo of a man wearing scrubs in front of a blue background
      Related Content

      PDF of Rx Road Map for subcutaneous daratumumab in multiple myeloma

      Rx Road Map: Subcutaneous Daratumumab in Multiple Myeloma

      Sylwia Zielinska, RN
      Published: May 7th 2025 | Updated: June 5th 2025
      Article

      A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.


      lung cancer

      Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)

      Denise Rouse, MMS, PA-C;Margaret Colleton, MMS, MSW, PA-C
      December 19th 2024
      Article

      APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.


      An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.

      Understanding the Role of an Oncology Research Nurse

      Darlene Dobkowski, MA
      September 26th 2024
      Article

      An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.


      nurse talking to male patient in radiation machine

      How Nurses Help Patients With Prostate Cancer During Radiation Treatment

      Alex Biese
      September 23rd 2024
      Article

      Nurses play a crucial role for patients with prostate cancer undergoing radiation treatment, according to a radiation oncology nurse.


      lungs

      Lung Cancer Trial Falls Short of Goal, But Presents Clinical Benefit in Some Patients

      Dylann Cohn-Emery
      September 17th 2024
      Article

      While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed promising long-term benefits in patients with advanced NSCLC.


      Suriyo - stock.adobe.com

      Innovative Program Reduces Nurse Turnover and Fosters Development

      Heather Wood, RN, OCN;Marie Garcia, RN, OCN
      Published: September 12th 2024 | Updated: September 12th 2024
      Article

      The US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.

      Related Content

      PDF of Rx Road Map for subcutaneous daratumumab in multiple myeloma

      Rx Road Map: Subcutaneous Daratumumab in Multiple Myeloma

      Sylwia Zielinska, RN
      Published: May 7th 2025 | Updated: June 5th 2025
      Article

      A registered nurse gives best practices for use of subcutaneous daratumumab in multiple myeloma.


      lung cancer

      Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)

      Denise Rouse, MMS, PA-C;Margaret Colleton, MMS, MSW, PA-C
      December 19th 2024
      Article

      APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.


      An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.

      Understanding the Role of an Oncology Research Nurse

      Darlene Dobkowski, MA
      September 26th 2024
      Article

      An oncology research nurse balances patient care with rigorous data collection, emphasizing communication and collaboration to advance cancer research.


      nurse talking to male patient in radiation machine

      How Nurses Help Patients With Prostate Cancer During Radiation Treatment

      Alex Biese
      September 23rd 2024
      Article

      Nurses play a crucial role for patients with prostate cancer undergoing radiation treatment, according to a radiation oncology nurse.


      lungs

      Lung Cancer Trial Falls Short of Goal, But Presents Clinical Benefit in Some Patients

      Dylann Cohn-Emery
      September 17th 2024
      Article

      While none of the experimental combinations met efficacy targets, durvalumab with monalizumab and ceralasertib showed promising long-term benefits in patients with advanced NSCLC.


      Suriyo - stock.adobe.com

      Innovative Program Reduces Nurse Turnover and Fosters Development

      Heather Wood, RN, OCN;Marie Garcia, RN, OCN
      Published: September 12th 2024 | Updated: September 12th 2024
      Article

      The US Oncology Network (The Network) has developed one of the most comprehensive programs in the nation to support the professional development and retention of new oncology nurses.

      Latest Conference Coverage

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

      AI Tool May Predict Response, Resistance in Advanced RCC

      Olanzapine May Reduce Nausea, Vomiting From Radiation

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.